These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15132777)

  • 1. The expressions of p21 and pRB may be good indicators for the sensitivity of esophageal squamous cell cancers to CPT-11: Cell proliferation activity correlates with the effect of CPT-11.
    Nakajima Y; Miyake S; Tanaka K; Ogiya K; Toukairin Y; Kawada K; Nishikage T; Nagai K; Kawano T
    Cancer Sci; 2004 May; 95(5):464-8. PubMed ID: 15132777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPT-11 may provide therapeutic efficacy for esophageal squamous cell cancer and the effects correlate with the level of DNA topoisomerase I protein.
    Nakajima Y; Miyake S; Nagai K; Kawano T; Iwai T
    Jpn J Cancer Res; 2001 Dec; 92(12):1335-41. PubMed ID: 11749700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.
    Wuerzberger SM; Pink JJ; Planchon SM; Byers KL; Bornmann WG; Boothman DA
    Cancer Res; 1998 May; 58(9):1876-85. PubMed ID: 9581828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of CPT-11 and SN-38 activities in human lung cancer cells.
    van Ark-Otte J; Kedde MA; van der Vijgh WJ; Dingemans AM; Jansen WJ; Pinedo HM; Boven E; Giaccone G
    Br J Cancer; 1998 Jun; 77(12):2171-6. PubMed ID: 9649129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc induces cell cycle arrest and apoptosis by upregulation of WIG-1 in esophageal squamous cancer cell line EC109.
    Guo W; Zou YB; Jiang YG; Wang RW; Zhao YP; Ma Z
    Tumour Biol; 2011 Aug; 32(4):801-8. PubMed ID: 21559779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
    Jones CB; Clements MK; Wasi S; Daoud SS
    Cancer Chemother Pharmacol; 1997; 40(6):475-83. PubMed ID: 9332461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin.
    Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z
    Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent alterations in the expression of tumor suppressor genes p16INK4A and pRb in esophageal squamous cell carcinoma in the Indian population.
    Ralhan R; Mathew R; Arora S; Bahl R; Shukla NK; Mathur M
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):655-60. PubMed ID: 11079730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and role of Aquaporin 5 in esophageal squamous cell carcinoma.
    Shimizu H; Shiozaki A; Ichikawa D; Fujiwara H; Konishi H; Ishii H; Komatsu S; Kubota T; Okamoto K; Kishimoto M; Otsuji E
    J Gastroenterol; 2014 Apr; 49(4):655-66. PubMed ID: 23657608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo.
    Zou J; Li S; Chen Z; Lu Z; Gao J; Zou J; Lin X; Li Y; Zhang C; Shen L
    Cell Death Dis; 2018 May; 9(6):661. PubMed ID: 29855512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers.
    Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T
    Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells.
    Gupta M; Fan S; Zhan Q; Kohn KW; O'Connor PM; Pommier Y
    Clin Cancer Res; 1997 Sep; 3(9):1653-60. PubMed ID: 9815856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death.
    Sané AT; Bertrand R
    Cancer Res; 1999 Aug; 59(15):3565-9. PubMed ID: 10446962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.
    Inoue Y; Tanaka K; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
    Int J Oncol; 2006 Feb; 28(2):479-86. PubMed ID: 16391804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation.
    Sorensen M; Sehested M; Christensen IJ; Larsen JK; Jensen PB
    Br J Cancer; 1998 Jun; 77(12):2152-61. PubMed ID: 9649127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11.
    Matsumoto Y; Fujiwara T; Honjo Y; Sasaoka N; Tsuchida T; Nagao S
    J Surg Oncol; 1993 Jun; 53(2):97-103. PubMed ID: 8388965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.